
FDA Generic Peptide Guidance 2026: What Changed?
FDA’s 2026 Generic Peptide Guidance: What Changed? Short answer: FDA’s generic peptide guidance update revised 17 product-specific guidances in July 2026. The drafts clarify recommendations for manufacturing approach, immune-response testing, impurity thresholds, higher-order structure, and biological activity. They do not approve a new generic product by themselves. The update matters because peptide drugs can be […]
Read Article



